BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Axsome Therapeutics Inc. (NASDAQ:AXSM)

2 posts

Biotech NewsWhy Axsome Therapeutics (AXSM) Keeps Winning in a Part of Pharma Everyone Else Quit

  • BioTech Health X
  • January 18, 2026
Built around the belief that neuroscience remains one of the most underserved and misunderstood frontiers in modern medicine,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAxsome (AXSM) Posts $150M Q2 Revenue, Beats EPS Expectations

  • BioTech Health X
  • September 5, 2025
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a biopharmaceutical company headquartered in New York City that is focused on…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • CalciMedica (CALC): High-Risk Biotech or Deep-Science Sleeper?
  • This Heart Drug Was Written Off — Now Amarin (AMRN) Is Back in the Game
  • Why Axsome Therapeutics (AXSM) Keeps Winning in a Part of Pharma Everyone Else Quit
  • This NASDAQ Stock Is Turning Skin Healing Into a Business—Meet AVITA Medical (RCEL)
  • Corvus Pharmaceuticals (CRVS): The Quiet Cancer Bet Wall Street Isn’t Talking About Yet
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 18, 2026
    CalciMedica (CALC): High-Risk Biotech or Deep-Science Sleeper?
    • January 18, 2026
    This Heart Drug Was Written Off — Now Amarin (AMRN) Is Back in the Game
    • January 18, 2026
    Why Axsome Therapeutics (AXSM) Keeps Winning in a Part of Pharma Everyone Else Quit
    • January 18, 2026
    This NASDAQ Stock Is Turning Skin Healing Into a Business—Meet AVITA Medical (RCEL)
    • January 18, 2026
    Corvus Pharmaceuticals (CRVS): The Quiet Cancer Bet Wall Street Isn’t Talking About Yet
Recent Posts
  • Why Madrigal Pharmaceuticals (MDGL) Is Suddenly on Every Biotech Watchlist
    • January 18, 2026
  • Structure Therapeutics (GPCR) Is Trying to Do What Big Pharma Still Hasn’t — Turn Obesity Drugs Into Pills
    • January 18, 2026
  • ImmunityBio (IBRX) Isn’t Chasing Hype—It’s Chasing Immune Memory
    • January 18, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (719)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top